Senate Bill 682 aims to regulate the sale of hemp-derived cannabinoid products in Wisconsin by establishing specific requirements and restrictions. The bill modifies the definition of hemp to include hemp-derived cannabinoid products and specifies that the qualifying criteria for hemp must be tested using high-performance liquid chromatography, gas chromatography-mass spectrometry, or other reliable methods. It introduces a new definition for hemp-derived cannabinoids and products, which includes various forms of THC, while excluding certain products such as prescription drugs approved by the FDA.

The bill prohibits the sale of hemp-derived cannabinoid products to individuals under 21 years of age and outlines the responsibilities of sellers to verify the age of purchasers. It mandates that manufacturers submit product samples for testing by accredited laboratories to ensure compliance with labeling and safety standards, including cannabinoid content and the absence of harmful substances. Additionally, products must be labeled with detailed information, including manufacturer contact details, serving sizes, and potency, and must be packaged in a child-resistant manner. The bill also clarifies that existing laws regarding hemp-related violations do not apply to the enforcement of these new provisions.

Statutes affected:
Bill Text: 94.55(1), 94.55